Rachida El Moussaoui
Overview
Explore the profile of Rachida El Moussaoui including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
237
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jongen V, Wit F, Boyd A, van Eeden A, Brouwer A, Soetekouw R, et al.
Lancet HIV
. 2025 Jan;
12(1):e40-e50.
PMID: 39779044
Background: Real-world data showing the long-term effectiveness of long-acting injectable cabotegravir and rilpivirine are scarce. We assessed the effectiveness of cabotegravir and rilpivirine in all individuals who switched to cabotegravir...
2.
Visser C, Sprenger R, van den Bout H, Boer D, El Moussaoui R, den Hollander J
Thromb Update
. 2024 Apr;
1:100006.
PMID: 38620665
Hypercoagulation is one of the most distinct prognostic factors of patients with COVID-19 and has been associated with arterial thrombosis and other venous thrombotic events (VTE). Bleeding complications are far...
3.
Smit J, Krijthe J, Tintu A, Endeman H, Ludikhuize J, van Genderen M, et al.
Intensive Care Med Exp
. 2022 Sep;
10(1):38.
PMID: 36117237
Background: Timely identification of deteriorating COVID-19 patients is needed to guide changes in clinical management and admission to intensive care units (ICUs). There is significant concern that widely used Early...
4.
van Steenkiste J, van Herwerden M, Weller D, van den Bout C, Ruiter R, den Hollander J, et al.
Heart Lung
. 2021 Jun;
50(5):654-659.
PMID: 34098235
Background: Invasive mechanical ventilation is the treatment of choice in COVID-19 patients when hypoxemia persists, despite maximum conventional oxygen administration. Some frail patients with severe hypoxemic respiratory failure are deemed...
5.
Hensley K, Jordans C, van Kampen J, Mollema F, Gisolf E, El Moussaoui R, et al.
Clin Infect Dis
. 2021 May;
74(3):521-524.
PMID: 33993276
During COVID-19 lockdown, the in-hospital number of HIV indicator conditions decreased disproportionally compared with other non-COVID-19 diseases, which was accompanied by reduced HIV testing rates, number and proportion of positive...
6.
Blomaard L, van der Linden C, van der Bol J, Jansen S, Polinder-Bos H, Willems H, et al.
Age Ageing
. 2021 May;
50(3):631-640.
PMID: 33951156
Background: During the first wave of the coronavirus disease 2019 (COVID-19) pandemic, older patients had an increased risk of hospitalisation and death. Reports on the association of frailty with poor...
7.
van Herwerden M, van Steenkiste J, El Moussaoui R, den Hollander J, Helfrich G, J A M Verberk I
Ned Tijdschr Geneeskd
. 2021 Mar;
165.
PMID: 33720552
Objective: To evaluate the implementation of home telemonitoring and oxygen therapy in COVID-19 patients. Primary outcomes were safety, patient satisfaction, reduction of hospital stay, and cost-effectiveness. Design: Retrospective cohort study....
8.
Bruns A, Oosterheert J, El Moussaoui R, Opmeer B, Hoepelman A, Prins J
J Gen Intern Med
. 2009 Dec;
25(3):203-6.
PMID: 19967464
Background: Chest radiographs are often used to diagnose community-acquired pneumonia (CAP), to monitor response to treatment and to ensure complete resolution of pneumonia. However, radiological exams may not reflect the...
9.
El Moussaoui R, Opmeer B, de Borgie C, Nieuwkerk P, Bossuyt P, Speelman P, et al.
Chest
. 2006 Oct;
130(4):1165-72.
PMID: 17035452
Study Objectives: The long-term outcomes of patients with community-acquired pneumonia (CAP) in terms of symptom resolution and health-related quality of life (HRQL) is unknown. Our objective was to determine the...
10.
El Moussaoui R, de Borgie C, van den Broek P, Hustinx W, Bresser P, van den Berk G, et al.
BMJ
. 2006 Jun;
332(7554):1355.
PMID: 16763247
Objective: To compare the effectiveness of discontinuing treatment with amoxicillin after three days or eight days in adults admitted to hospital with mild to moderate-severe community acquired pneumonia who substantially...